13F Data
13F filer · CIK 1618205

Birchview Capital, LP

BURLINGTON, VT · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$213.8M
+$38.2M vs prior
Positions
72
New / sold out
14 / 15
Added / reduced
18 / 21
Turnover
16.6%
buys $70.7M · sells $32.3M
Top-10 weight
59.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedKLA CORPORATION+158,588+797.6%+$47.8M
AddedNEKTAR THERAPEUTICS+50,000+161.3%+$3.5M
NewABIVAX SA+17,000–+$2.3M
NewVIR BIOTECHNOLOGY INC+220,000–+$2.2M
AddedHALOZYME THERAPEUTICS INC+23,151+229.2%+$1.8M
NewBIOAGE LABS INC+69,000–+$1.7M
NewNOVO NORDISK A/S+24,000–+$1.2M
NewADAGENE INC+240,000–+$1.0M
NewDEFINIUM THERAPEUTICS INC+20,000–+$940.8K
AddedCORCEPT THERAPEUTICS INC+10,000+21.2%+$869.5K
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedCOMPASS PATHWAYS LTD-345,000-92.0%$-4.9M
ReducedSTRUCTURE THERAPEUTICS INC-76,000-76.0%$-4.1M
ReducedOCULAR THERAPEUTIX INC-299,345-93.5%$-2.9M
ReducedUNIQURE NV-50,000-49.7%$-2.3M
Sold outNOVOCURE LTD-202,330-100.0%$-2.2M
Sold outENGENE HOLDINGS INC-250,000-100.0%$-1.7M
ReducedPHATHOM PHARMACEUTICALS INC-140,000-71.8%$-1.5M
Sold outULTRAGENYX PHARMACEUTICAL INC-62,000-100.0%$-1.3M
Sold outKALVISTA PHARMACEUTICALS INC-57,000-100.0%$-1.1M
ReducedINTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026-59,500-13.4%$-1.0M
26 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $172.2MQ1 2015: $190.3MQ2 2015: $189.3MQ3 2015: $155.4MQ4 2015: $173.7MQ1 2016: $140.3MQ2 2016: $137.8MQ3 2016: $171.3MQ4 2016: $162.5MQ1 2017: $179.8MQ2 2017: $189.0MQ3 2017: $193.6MQ4 2017: $170.6MQ1 2018: $151.9MQ2 2018: $147.1MQ3 2018: $154.9MQ4 2018: $105.7MQ1 2019: $159.6MQ2 2019: $164.4MQ3 2019: $150.1MQ4 2019: $137.6MQ1 2020: $112.7MQ2 2020: $165.5MQ3 2020: $149.7MQ4 2020: $173.6MQ1 2021: $168.4MQ2 2021: $167.2MQ3 2021: $147.0MQ4 2021: $155.1MQ1 2022: $138.9MQ2 2022: $137.5MQ3 2022: $142.0MQ4 2022: $141.6MQ1 2023: $127.7MQ2 2023: $133.4MQ3 2023: $235.2MQ4 2023: $255.4MQ1 2024: $245.2MQ2 2024: $216.2MQ3 2024: $230.7MQ4 2024: $245.6MQ1 2025: $115.2MQ2 2025: $100.7MQ3 2025: $132.4MQ4 2025: $170.8MQ1 2026: $175.7MQ2 2026: $213.8M
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1KLA CORPORATIONCOM NEW178,471$53.8M25.18%
2BRISTOL-MYERS SQUIBB COCOM297,243$17.1M8.01%
3LAM RESEARCH CORPORATIONCOM NEW35,000$15.2M7.09%
4INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026COM385,900$6.8M3.17%
5SOLID BIOSCIENCES INCCOM NEW666,196$6.7M3.11%
6BIODESIX INCCOM286,804$6.5M3.02%
7STOKE THERAPEUTICS INCCOM178,110$5.8M2.73%
8OVINTIV INCCOM107,500$5.7M2.65%
9NEKTAR THERAPEUTICSCOM81,000$5.7M2.64%
10CORCEPT THERAPEUTICS INCCOM57,200$5.0M2.33%
62 more rows. Subscribe for $29/month to see every row, download the data and use the API.